January 12, 2017
MaxCyte’s in Demonstrates CRISPR-Cas9 X-linked CGD gene repair study
MaxCyte has been engaged in a study with National Institutes of Health’s (NIH) allergy and infection section to show certain CYBB gene behaviour in patients with X-linked chronic granulomatous disease (X-CGD).